FACULTY PUBLICATIONS 2002-2003

BALOH, ROBERT

1. Tang, Y, Lopez I, Baloh RW: Age-related change of the neuronal number in the human medial vestibular nucleus: stereological investigation. J Vest Res 2001-2002;11:357-363.


2. Baloh RW: Robert Barany and the controversy surrounding his discovery of the caloric reaction. Neurology 2002;58:1094-1099.


3. Jen J, Coulin CJ, Bosley T, Sabatti C, Nelson SF, Baloh RW: Familial horizontal gaze palsy with progressive scoliosis maps to chromosome 11q23-25, Neurology 2002;59:432-435.


4. Baloh RW: Episodic vertigo: Central nervous system causes. Curr Opin Neurol 2002;15:17-21.


5. Baloh RW, Jen JC: Genetics of familial episodic vertigo and ataxia. Ann NY Acad Sci 2002;956:338-345.


6. Jen JC, Baloh RW: Genetics of episodic ataxia. Adv. Neurol 2002;89:459-461.


7. Wiest G, Baloh RW: Sigmund Freud and the eighth cranial nerve. Otol Neurology 2002;23:228-232.


8. Wiest G, Baloh RW: The pioneering work of Josef Breuer on the vestibular system. Arch Neurol 2002;59:1647-1653.


9. Lee H, Sohn SI, Jung DK, Cho YW, Lim JG, Yi SD, Lee SR, Sohn CH, Baloh RW: Sudden Deafness and Anterior Inferior Cerebellar Artery Infarction. Stroke 2002;33:2807-2812.

1. Carmichael ST, Chesselet.M-F Synchronous neuronal activity is a signal for axonal sprouting after cortical lesions in the adult. . Neurosci. 22:6062-6070, 2002.


2. Carmichael ST New Laboratory Start-Up in the 21st Century. Trends Neurosci 25: 287-288, 2002.

1. Toneff T, Mende-Mueller L , Wu Y, Hwang SR, Bundney R, Aaron W, Thompson LM, Chesselet M-F, and Hook V: Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain. J. Neurochem. 82 (2002) 84-92.


2. Carmichael S.T. and Chesselet M-F: Synchronous Neuronal Activity is a signal for Axonal Sprouting after Cortical Lesions in the Adult. J. Neuroscience, 22 (2002) 6062-6070.


3. Menalled L.B., Sison J., Li X-J, Li H., Zeitlin S. and Chesselet, M-F: Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock in mice. J. Neuroscience, 22 (2002) 8266-8276.


4. Romero-Ramos M., Vourc'h P, Young H, Lucas P, Chivatakarn O, Dunkelman N, El-Kalay M, and Chesselet M-F: Neuronal differentiation of stem cells isolated from adult muscle. J. Neuroscience Research, 69 (2002) 894-907.


5. Menalled LB., and Chesselet M-F: Mouse models of Huntington's disease. Trends in Pharmacological Science, 23 (2002) 32-39.

1. Gauthier S, Cummings JL. Alzheimer’s Disease and Related Disorders Annual 2002. Martin


2. Dunitz, London, England, 2002.


3. Cummings JL, Cole G. Alzheimer disease. JAMA 2002;287:2335-2338.


4. Cummings JL, Street J, Masterman D, Scott Clark W. Efficacy of olanzapine in the treatment of psychosis in dementia with Lewy bodies. Dement Geriatri Cogn Disord 2002;13:67-73.


5. Senanarong V, Vannasaeng S, Poungvarin N, Ploybutr S, Udompunthurak S, Jamjumras P, Fairbanks L, Cummings JL. Endogenous estradiol in elderly individuals. Arch Neurol 2002;59:385-389.


6. Chow TW, Liu CK, Fuh JL, Leung VPY, Tai CT, Chen L-W, Wang SJ, Chiu HFK, Lam LCW, Chen QL, Cummings JL. Neuropsychiatric symptoms of Alzheimer’s disease differ in Chinese and American patients. Int J Geriatr Psychiatry 2002;17:22-28.


7. Pang FC, Chow TW, Cummings JL, Leung VPY, Chiu HFK, Lam LCW, Chen QL, Tai CT, Chen LW, Wang SJ, Fuh JL. Effect of neuropsychiatric symptoms of Alzheimer’s disease on Chinese and American caregivers. Int J Geriatr Psychiatry 2002;17:29-34.


8. Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Ranga Rama Krishman K, Lyketsos CG, Lyness JM, Rabins PV, Reynolds CF III, Rovner BW, Steffens DC, Tariot PN, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatri Psychiatry 2002;10:125-128.


9. Rosen HJ, Hartikainen KM, Jagust W, Kramer JH, Reed BR, Cummings JL, Boone K, Ellis W, Miller C, Miller BL. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58:1608-1615.


10. Cummings JL, Frank JC, Cherry D, Kohatsu ND, Kemp B, Hewett L, Mittman B. Guidelines for managing Alzheimer’s disease: Part I. Assessment. Am Fam Physician 2002;65:2263-2272.


11. Ringman JM, Diaz-Olavarrieta C, Rodriguez Y, Fairbanks L, Cummings JL. The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson’s disease in Mexico. Neuropsychiatry Neuropsychol Behav Neurol 2002;15:99-105.


12. Cummings JL, Grossman M, Mayeux R, Scharre D. How to treat dementia in its early stages. Practical Neurology 2002;60.


13. McPherson S, Fairbanks L, Tiken S, Cummings JL, Back-Madruga C. Apathy and executive function in Alzheimer’s disease. J Int Neuropsychol Soc 2002;8:373-381.


14. Cummings J. Behavioral characteristics in diagnosis. In: Evidence-based Dementia Practice. Qizilbash N (ed). Blackwell Science Publishing Company, Oxford, 2002, pp. 124-129.


15. McPherson S, Cummings JL. The frontal lobes and frontal-subcortical


16. circuits in neuropsychiatric disorders. In: Handbook of Neuropsychology, 2nd Edition. Boller F, Grafman J (eds). Elsevier Science, Amsterdam, 2002, pp. 99-116.


17. Askin-Edgar S, White KE, Cummings JL. Neuropsychiatric aspects of Alzheimer’s disease and other dementing illnesses. In: The American Publishing Textbook of Neuropsychiatry and Clinical Neurosciences, 4th Edition. Yudofsky SC, Hales RE (eds). American Psychiatric Publishing, Inc., Washington, DC, 2002, pp. 953-988.


18. Mega MS, Thompson PM, Toga AW, Cummings JL. Hippocampal volume assessment in mild cognitive impairment. In: Drug Discovery and Development for Alzheimer’s Disease. Fillit HM, O’Connell AW (eds). Springer Publishing Company, New York, NY, 2002, pp. 33-41.


19. Chow TW, Masterman DL, Cummings JL. Depression. In: Parkinson’s Disease: Diagnosis and Clinical Management. Factor SA, Weiner WJ (eds). Demos Medical Publishing, Inc., New York, NY, 2002, pp. 145-159.


20. Porter VR, Cummings JL. Dementia. In: Women’s Health: Principles and Clinical Practice. Pregler JP, DeCherney AH (eds). B.C. Decker, Inc., London, 2002, pp. 697-707.


21. Senanarong V, Cummings JL. Adopting dementia assessments for international application. In: Alzheimer’s Disease and Related Disorders Annual 2002. Gauthier S, Cummings JL (eds). Martin Dunitz, London, England, 2002, pp. 87-96.


22. Assal F, Cummings JL. Neuropathological changes underlying neuropsychiatric symptoms in Alzheimer’s disease. In: Alzheimer’s Disease and Related Disorders Annual 2002. Gauthier S, Cummings JL (eds). Martin Dunitz, London, England, 2002, pp. 199-215.

1. Sorvillo F, Ash L, Berlin O, Yatabe J, DeGiorgio C, Morse S. Baylisascaris procyonis: an emerging helminthic zoonosis. Emerging Infectious Diseases, 2002;8:355-359.


2. DeGiorgio CM, Houston I, Oviedo S, Sorvillo F. Death associated with Cysticercosis: Report of three cases and review of the literature. Neurosurgical Focus 2002;12:(6) 1-4.

1. Tian, J. -R., Shubayev, I., and Demer, J. L. Dynamic visual acuity during passive and self-generated transient head rotation in normal and unilaterally vestibulopathic humans. Exp. Brain Res. 142:486-495, 2002.


2. Clark, R. A. and Demer, J. L. Rectus extraocular muscle pulley displacement after surgical transposition and posterior fixation for treatment of paralytic strabismus. Am. J. Ophthalmol. 133:119-28, 2002.


3. Demer, J. L. The orbital pulley system – A revolution in concepts of orbital anatomy. Ann. N.Y. Acad. Sci. 956: 17-32, 2002.


4. Tian, J. –R., Crane, B. T., Wiest, G., and Demer, J. L. Impaired linear vestibulo-ocular reflex initiation and vestibular catch-up saccades in older persons. Ann. N.Y. Acad. Sci. 956: 574-578, 2002.


5. Durig, J. S., Jen, J. C., Demer, J. L. Ocular motility in genetically defined autosomal dominant cerebellar ataxia. Am. J. Ophthalmol. 133:718-721, 2002.


6. Sharma, P., Rosenbaum, A. L., Vives, T., Grody, W., and Demer, J. L. Discordant pursuit asymmetry and esotropia in monozygous twins. Am. J. Ophthalmol. 134: 143-146, 2002.


7. Oh, S. Y., Clark, R. A., Velez, F., Rosenbaum, A. L., and Demer, J. L. Incomitant strabismus associated with instability of rectus pulleys. Invest. Ophthalmol. Vis. Sci. 43: 2169-2178, 2002.


8. Weng, V., Demer, J. L., Rosenbaum, A., and Weissman, B. Glaucoma in pediatric aphakia. Optometry: J. Am. Optom. Ass’n. 73:704-710, 2002.


9. Kono, R., Clark, R. A., and Demer, J. L. Active pulleys: Magnetic resonance imaging of rectus muscle paths in tertiary gazes. Invest. Ophthalmol. Vis. Sci. 43: 2179-2188, 2002.


10. Kono, R., Poukens, V., and Demer, J. L. Quantitative analysis of the structure of the human extraocular muscle pulley system, Invest. Ophthalmol. Vis. Sci.43: 2923-2932, 2002.


11. Tian, J. R., Crane, B. T., Wiest, G., and Demer, J. L. Effect of aging on the initial human interaural linear vestibulo-ocular reflex. Exp. Brain Res. 145: 142-149, 2002.


12. Clark, R. A., and Demer, J. L. Effect of aging on human rectus extraocular muscle paths demonstrated by magnetic resonance imaging. Am. J. Ophthalmol. 134:872-878, 2002.

1. Bragin, A., Mody, I., Wilson, C.L. and Engel, J. Jr. Local generation of fast ripples in epileptic brain. J. Neurosci. 22:2012-2021, 2002.


2. Bragin, A., Wilson, C.L. and Engel, J. Jr. Increased afterdischarge threshold during kindling in epileptic rats. Exp. Brin Res. 144:30-37, 2002.


3. Bragin, A., Wilson, C.L. and Engel, J. Jr. Rate of interictal events and spontaneous seizures in epileptic rats after electrical stimulation of hippocampus and its afferents. Epilepsia 43 (Suppl. 5):81-85, 2002.


4. Bragin, A., Wilson, C.L., Staba, R.J., Reddick, MS., Fried, I. and Engel, J. Jr. Interictal high frequency oscillations (80-500Hz) in the human epileptic brain: Entorhinal cortex. Ann. Neurol. 52:407-415, 2002.


5. Cornford, E.M., Shamsa, K., Zeitzer, J.M., Enriquez, C.M., Wilson, C.L., Behnke, E.J., Fried, I. and Enge, J. Jr. Regional analyses of CNS microdialysate glucose and lactate in seizure patients. Epilepsia 43:1360-1371, 2002.


6. Eliashiv, D.S., Elsas, S.M., Squires, k., Fried, I. and Engel, J. Jr. Ictal magneticsouce imaging as a localizing tool in partial epilepsy. Neurology 59:1600-1610, 2002.


7. Engel, J. Jr. Epilepsy in the world today: The medical point of view. Epilepsia 43 (Suppl. 6):12-13, 2002.


8. Engel, J. Jr. So what can we conclude – do seizures damage the brain? Prog. Brain Res. 135:509-512, 2002.


9. Engel, J. Jr. When to refer for surgery. Practical Neurology 1:28-35, 2002.


10. Engel, J. Jr., Wilson, C., Lopez-Rodriguez, F. Limbic connectivity: anatomical substrates of behavioral disturbances in epilepsy. In: Trimble, M., Schmitz, B. (Eds.), The Neuropsychiatry of Epilepsy. Cambridge: University Press, 2002, pp. 18-37.


11. Goldman, R.I., Stern, J.M., Engel, J. Jr. and Cohen, M.S. Simultaneous EEG and fMRI of the alpha rhythm. NeuroReport 13:2487-2492, 2002.


12. Mazarati, A., Bragin, A., Baldwin, R., Shin, D., Wilson, C., Cankar, R., Naylor, D., Engel, J. Jr. and Wasterlain, C.G. Epileptogenesis after self-sustaining status epilepticus. Epilepsia 43(Suppl. 5):74-80, 2002


13. Mintzer, S., Nicholl, J.S., Stern, J.M. and Engel, J. Jr. Relative utility of sphenoidal and temporal surface electrodes for localization of ictal onset in temporal lobe epilepsy. Clin.


14. Neurophysiol. 113:911-916, 2002.


15. Staba, R.J., Wilson, C.L., Bragin, A., Fried, I. and Engel, J.Jr. Sleep states differentiate single neuron activity recorded from human epileptic hippocampus, entorhinal cortex and subiculum. J. Neurosci. 22:5694-5704, 2002.


16. Staba, R.J., Wilson, C.L., Bragin, A., Fried, I. and Engel, J.Jr. Quantitative analysis of high frequency oscillations (80-500Hz) recorded in human epileptic hipposcampus and entorhinal cortex. Neurophysiol. 88:1743-1752, 2002.


17. Staba, R.J., Wilson, Fried, I. and Engel, J.Jr. Single unit burst firing in the human hippocampus during sleep. Hippocampus 12:724-734, 2002.


18. Zeitzer, J.M., Maidment, N.T., Behnke, E.J., Ackerson, L.C., Fried, I., Engel, J. Jr. and Wilson, C.L. ultradian sleep-cycle variation of serotonin in the human lateral ventricle. Neurology 59:1272-1274, 2002.

1. X Sun, GM Cole, T Chu, W Xia, D Galasko, H Yamaguchi, K Tanemura, SA. Frautschy and A Takashima. Intracellular Aß is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines. Neurobiology of Aging 23:195-203, 2002.

1. Fujikawa, DG, Ke, X, Trinidad, RB, Shinmei, SS and Wu, A. Caspase-3 is not activated in seizure-induced neuronal necrosis with internucleosomal DNA cleavage. J Neurochem, 83: 229-240, 2002.


2. Fujikawa, DG. Apoptosis: ignoring morphology and focusing on biochemical mechanisms will not eliminate confusion. Trends Pharmacol Sci, 23: 309-310, 2002 (comment).


3. Fujikawa, DG. PARP-1 and AIF produce cellular necrosis, not apoptosis. Science Online Debates, 297: 200-201, 2002 (response to a Science Perspectives article).


4. Wu, A., and Fujikawa, DG. Effects of AMPA-receptor and voltage-sensitive sodium channel blockade on high potassium-induced glutamate release and neuronal death in vivo. Brain Res, 946: 119-129, 2002.


5. Licht, EA, Jocobsen, RH, and Fujikawa, DG. Chronically impaired frontal lobe function from subclinical epileptiform discharges. Epilepsy Behav, 3: 96-100, 2002.


6. Licht, EL, and Fujikawa, DG. Nonconvulsive status epilepticus with frontal features: quantitating severity of subclinical epileptiform discharges provides a marker for treatment efficacy, recurrence and outcome. Epilepsy Res, 51: 13-21, 2002.

1. Maegele, M., S. Muller, A. Wernig, V.R. Edgerton, and S.J. Harkema. Recruitment of spinal motor pools during voluntary movements versus stepping after human spinal cord injury. Journal of Neurotrauma, 19, 10, 1217-1229, 2002.


2. Reinkensmeyer, D.J., J.H. Wynne, and S.J. Harkema. A robotic tool for studying locomotor adaptation and rehabilitation. Submitted to the Second Joint Meeting of the IEEE Engineering in Medicine and Biology Society and the Biomedical Engineering Society, October 23-26, 2002, Houston, Texas.

1. Keesey JC & Sonshine R. A practical guide to myasthenia gravis; a handbook for patients & families, 3rd edition, Myasthenia Gravis Foundatio., 24 pages, 2002.


2. Keesey JC. “Cisis” in myasthenia gravis: An historical perspective. Muscle & Nerve 26: 1-3, July 2002.

1. Aziz-Zadeh, L., Maeda, F., Zaidel, Ed., Mazziotta, J. & Iacoboni, M. Lateralization in motor facilitation during action observation: A TMS study. Exp Brain Res. 144(1): 127-131, 2002.


2. Koski, L., Wohschlager, A., Bekkering, H., Woods, R., Dubeau, M-C., Mazziotta, J. & Iacoboni, M. Modulatiom of motor and premotor activity during imitation of target-diected actions. Cerebral Cortex. 12: 847-855, 2002.


3. Narr, K.L., Cannon, T.D., Woods, R.P., Thompson, P.M., Kim, S., Asunction, D., can Erp, T.G.M.c, Poutanen, V-P., Huttunen, M., Lonnqvist, J., Standerksjold-Nordenstam, C-G. Kaprio, J., Mazziotta, J. & Toga, A.W. A twin study of genetic contributions to hippocampal morphology in schizophrenia. Neurobiology of Disease. 11(1): 83-95, 2002.


4. Narr, K.L., Cannon, T.D., Woods, R.P., Thompson, P.M., Kim, S., Asunction, D., can Erp, T.G.M.c, Poutanen, V-P., Huttunen, M., Lonnqvist, J., Standerksjold-Nordenstam, C-G. Kaprio, J., Mazziotta, J. & Toga, A.W. Genetic contributions to altered callosal morphology in schizophrenia. Journal of Neuroscience. 22(9): 3720-3729, 2002.


5. Koski, L., Iacoboni, M. & Mazziotta, J.C. Deconstruction apraxia: Understanding disorders of intentional movement after stroke. Current Opinion in Neurology. 15(1): 71-77, 2002.


6. Mazziotta, J.C. ICBM: A probabilistic atlas and referernce system for the human brain. In (Toga AW, Mazziotta JC, eds) Brain Mapping: The Methods, 2nd Edition, Academic Press, Elsevier Sciences, Amsterdam, 2002, pp. 722-755.


7. Mazziotta, J.C. Time and space. In (Toga AW, Mazziotta JC, eds) Brain Mapping: The Methods, 2nd Edition, Academic Press, Elsevier Sciences, Amsterdam, 2002, pp. 33-46.


8. Mazziotta, J.C. & Toga, A.W. Speculations on the future. In (Toga AW, Mazziotta JC, eds) Brain Mapping: The Methods, 2nd Edition, Academic Press, Elsevier Sciences, Amsterdam, 2002, pp. 829-856.

1. Hajos N, Freund TF, Mody I. Comparison of single NMDA receptor channels recorded on hippocampal principal cells and oriens/alveus interneurons projecting to stratum lacunosum-moleculare (O-LM cells). Acta Biol Hung. 2002;53(4):465-72.


2. Chui CS, Jensen K, Sokolova I, Wang D, Li M, Deshpande P, Dacidson N, Mody I, Quick MW, Quake SR, Lester HA. Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions. J Neurosci. 2002; 22(23):10251-66.


3. Behr J, Gebhardt C, Heinemann U, Mody I. Kindling enhances kainite receptor-mediated depression of GABAergic inhibition in rat granule cells. Eur J Neurosci. 2002; 6(5):861-7.


4. Wisden W, Cope D, Klausberger T, Hauer B, Sinkkonen ST, Tretter V, Lujan R, Jones A, Korpi ER, Mod I, Sieghart W, Somogyi P. Ectopic expression of the GABA(A) receptor alpha6 suunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology 2002; 43(4):530-49.


5. Stell BM, Mody I. Receptors with different affinities mediate phasic and tonic GABA (A) conductances in hippocampal neurons. J. neurosci. 2002, 22(10):RC223 (Online only).


6. Nusser Z, Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus cells. J. Neurophysiol. 2002, 87(5) 2624-2628.


7. Bragin A, Mody I, Wilson C, Engel J Jr. Local generation of fast ripples in epileptic brain. J. Neurosci. 2002, 22(5) 2012-2021.

1. Cohen, JA, Cutter, GR, Fischer, JS, et al for the IMPACT Investigators: Benefit of interferon beta 1a on MSFC progression in secondary progressive MS. Neurology 59: 679-687, 2002.


2. Panitch, H, Goodin, DS, Francis, G, for the EVIDENCE Study Group and the University of British Columbia MS/MRI Research Group: Randomized comparative study of interferon beta 1a treatment regimen in MS. The EVIDENCE Trial. Neurology 59: 1496-1506. 2002.

1. Perlman S. Bay J-O, Uhrhammer N, Gatti, RA. Ataxia-telangiectasia and variants. In: M-U Manto and M Pandolfo (eds) The Cerebellum and Its Disorders. Cambride University Press, Cambridge, 2002.


2. Perlman, SL Spinocerebellar Degenerations: An Undate. Current Neurology and Neuroscience Reports 2:331-341, 2002.


3. Perlman, SL. Post-Polio Syndrome: A Primary Neuromuscular Disease and Risk Factor for Morbidity in the Older Adult (CME article in two parts). Geriatric Times September/October, November/December issues, 2002.


4. Perlman, SL Late-onset Tay-Sachs disease as a Friedreich ataxia phenocopy. Arch Neurol 59: 1832, 2002.

1. Porter, VR and Cummings, JL. Dementia in Women. In: J. Pregler and A. DeCherney, Eds. Principles of Women’s Health. B.C. Decker Inc., London, 2002 pp. 697-703.

1. Rausch, R. Short and Long Term of Effects of Temporal Lobe Surgery. Current Opinions in Neurology, 2002, 15:185-189.

1. Kidwell CS, Saver JL, Carneado J, Sayre J, Starkman S, Duckwiler G, Gobin YP, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Vinuela F. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002;33:717-24.


2. Kidwell CS, Saver JL, Villablanca JP, Duckwiler G, Fredieu A, Gough K, Leary MC, Starkman S, Gobin YP, Jahan R, Vespa P, Liebeskind DS, Alger JR, Vinuela F. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke 2002;33:95-8.


3. Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL. Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association). Neurology 2002;59:13-22.


4. Saver JL, Kidwell CS, Starkman S. Commentary: Thrombolysis in stroke: it works! British Medical Journal 2002;324:727-729.


5. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG, for the TIA Working Group. Transient ischemic attack – proposal for a new definition. New England Journal of Medicine 2002;347:1713-1716.


6. Kidwell CS, Saver JL, Starkman S, Duckwiler G, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Gobin YP, Vinuela F, Alger JR. Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Annals of Neurology 2002;52:698-703.


7. Saver JL. Acute ischemic stroke. In: Johnson RT, Griffin JW, McArthur JC, eds. Current Therapy in Neurologic Disease. St. Louis: Mosby, 2002.


8. Saver JL. Approach to the patient with aphasia. In: Biller J, ed. Practical Neurology, 2nd edy. Philadelphia: Lippincott Williams & Wilkins, 2002.


9. Saver JL. Aggression. In: Ramachandran VS, ed. The Encyclopedia of the Human Brain. San Diego: Academic Press, 2002.

1. Guerrini R, Parmeggiani L, Shewmon A, Rubboli G, Tassinari CA: Motor dysfunction resulting from epileptic activity involving the sensorimotor cortex. In: Guerrini R, Aicardi J, Andermann F, Hallett M (eds): Epilepsy and Movement Disorders, Cambridge University Press, 2002, pp. 77-96.


2. Shewmon DA: Determinación del momento de la muerte: nuevas evidencias, nuevas controversias. In: González AMG, Solana EP and Jiménez SA (eds): Vivir y Morir con Dignidad Temas fundamentales de Bioética en una sociedad plural. Pamplona, Spain, EUNSA (Ediciones Universidad de Navarra), 2002, pp. 153-171.


3. Shewmon DA: The minimally conscious state: Definition and diagnostic criteria. Neurology 58(3):506, 2002.

1. Goldman RI, Stern JM, Engel J, Cohen MS. Simultaneous EEG and fMRI of the occipital alpha rhythm. NeuroReport 2002;13:2487-2492.


2. Mintzer S, Nicholl JS, Stern JM, Engel J. Relative utility of sphenoidal and temporal surface electrodes for localization of ictal onset in temporal lobe epilepsy. Clin Neurophysiol 2002;113:911-916.

1. Dinov, I.D., Mega, M.S., Thompson, P.M., Woods, RP., Sumners, D.W.L., Sowell, E.R. & Toga, A.W. Quantitative comparison and analysis of image registration using frequency-adaptive wavelet shrinkage. IEEE-T-ITB, 6(1): 73-85, 2002.


2. Toga, AW. Imaging databases and neuroscience, The Neuroscientist, 8(5): 423-436, 2002.


3. Pouratian N, Rex D, Sicotte S, Martin NA, Becker D, Cannestra AD & Toga AW Spatial/temporal correlation of BOLD and optical intrinsic signals in humans. Magnetic Resonance in Medicine, 47:766-776, 2002.


4. Toga AW & Thompson PM New approaches in Brain Morphometry. Am. J. Geriatr. Psychiatry, 10(1): 13-23, 2002.


5. Thompson PM & Toga AW A framework for computational anatomy. Computing Vis. & Science, 5:13-34, 2002.


6. Blood AJ, Pouratian N & Toga AW Temporally staggered forelimb stimulation modulates barrel cortex optical intrinsic signal responses to whisker stimulation. J. Neurophys., 88:422-437, 2002.


7. Sowell ER, Thompson PM, Mattson SN, Tessner KD, Jernigan TL, Riley EP & Toga AW Regional brain shape abnormalities persist into adolescence after heavy prenatal alcohol exposure. Cerebral Cortex, 12:856-865, 2002.


8. Toga AW Neuroimage databases: The good, the bad and the ugly, Nature Reviews Neuroscience, 3(4): 302-309, 2002.


9. Cannon TD, Thompson P, van Erp T, Toga AW, Poutanen VP, Hutteunen M, Lonnqvist J, Standertskjold-Nordenstam CG, Narr KL, Khaledy M, Zoumalen CI, Dail R & Kaprio J Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia, PNAS, Vol. 99 (5):3228-3233, 2002.


10. Pitiot, A., Toga, A.W and Thompson, P.M. Adaptive elastic segmentation of brain MRI via shape model guided evolutionary programming, IEEE Trans. on Medical Imaging, 21(8) 910-923, 2002.


11. Kumar A, Thomas A, Lavretsky H, Yue K, Huda A, Curran J, Venkatraman T, Estanol L, Mintz J, Mega M & Toga AW Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy, Am. J. Psychiatry, 159:630-636, 2002.
    
    Pouratian N, Bookheimer SY, Rex D, Martin NA & Toga AW The utility of preoperative functional magnetic resonance imaging for identifying language cortices in patients with vascular malformations, Journal of Neurosurgery, 97:21-32, 2002.


12. Narr KL, Cannon TD, Woods RP, Thompson PM, Kim S, Asuncion D, van Erp TGM, Poutanen VP, Huttunen M, Lonnqvist J, Standerksjold-Nordenstam CG, Kaprioo J, Mazziotta JC & Toga AW Genetic contributions to altered callosal morphology in Schizophrenia, Journal of Neuroscience, 22(9):3720-3729, 2002.


13. Thompson P, Cannon TD & Toga AW Mapping genetic influences on human brain structure, Annals of Medicine, 34:523-536, 2002.


14. Ba AM, Guiou M, Pouratian N, Muthialu A, Rex DE, Cannestra AF, Chen JWY & Toga AW Multiwavelength optical intrinsic signal imaging of cortical spreading depression, J. Neurophysiology, 88:2726-2735, 2002.


15. Narr KL, van Erp T, Cannon TD, Woods RP, Thompson PM, Jang S, Blanton R, Poutanen VP, Huttenen M, Lonnqvist J, Standerskjold-Nordenstam CG, Kaprio J, Mazziotta JC & Toga AW A twin study of genetic contributions to hippocampal morphology in Schizophrenia, Neurobiology of Disease, 11:83-95, 2002.


16. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Doddrell DM, Cannon TD & Toga AW Detecting dynamic and genetic effects on brain structure using high-dimensional cortical pattern matching, Proc. Int’l. Symposium on Biomedical Imaging, ISBI 2002, Washington, D.C., July 7-10, 2002.


17. Pouratian N, Cannestra AF, Martin N, Becker D & Toga, AW Intraoperative optical intrinsic signal imaging: a clinical tool for functional brain mapping, Neurosurgical Focus, 13(4):1-9, 2002.


18. Amari SI, Beltrame F, Bjaalie JG, Dalkara T, De Schutter E, Egan GF, Goddard NH, Gonsalez C, Grillner S, Herz A, Hoffmann KP, Jaaskelainen I, Koslow SH, Lee SY, Matthiessen L, Miller PL, da Silva FM, Novak M, Ravindranath V, Ritz R, Ruotsalainen U, Sebestra V, Subramaniam V, Yiyuan T, Toga AW, Usui S, van Pelt J, Verschure P, Willshaw D, & Wrobel A Neuroinformatics: The integration of shared databases and tools towards integrative neuroscience, J. Integrative Neurosci., Vol. 1 (2): 117-128, 2002.


19. Sowell ER, Thompson PM, Peterson BS, Mattson SN, Welcome SE, Henkenius AL, Riley EP, Jernigan TL & Toga AW Mapping cortical gray matter asymmetry patterns in adolescents with heavy prenatal alcohol exposure, NeuroImage, 17:1807-1819, 2002.


20. Thompson PM, Rapoport JL, Cannon TD & Toga AW Imaging the brain as schizophrenia develops: Dynamic & genetic brain maps, Primary Psychiatry, 9(11):40-47, 2002.
    
    Kochunuv P, Lancaster J, Thompson P, Toga AW, Brewer P, Hardies J & Fox P An optimized individual target brain in the talairach coordinate system, NeuroImage, 17(2):922-927, 2002.

1. Chang A, Tourtellotte WW, Rudick R, Trapp BDL Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346/3: 165-173, 2002.


2. Mann MB, Wu S, Rostamkhani M, Tourtellotte W, MacMurray J, Comings DE: Association between Phenylethanolamine N-Methyltransferase (PNMT) gene and multiple sclerosis. Journal of Neuroimmunology. 124(1-2):101-5, 2002.


3. Ke D, Syndulko K, Tourtellotte WW: structural equations modeling in the assessment of multiple sclerosis disease status. J Acta Neurologica Taiwanica 11/3: 135-143, 2002.

1. Birbeck GL, Hays RD, Cui X, Vickrey BG. Seizure reduction and quality-of-life improvements in people with epilepsy. Epilepsia 2002;43:535-538.


2. Morton SC, Shekelle PG, Adams JL, Bennett C, Dobkin B, Montgomerie J, Vickrey BG. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Archives of Physical Medicine and Rehabilitation 2002;83:129-138.


3. Swarztrauber K, Vickrey BG, Mittman BS. Physicians’ preferences for specialty involvement in the care of patients with neurological conditions. Medical Care 2002;40:1196-1209.


4. Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB, Garber S, McCaffrey DF, Dake MD, Levin RA. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 2002;33:901-906.

1. Sicotte, N., Liva, S.M., Klutch, R., Pfieffer, P., Bouvier, S., Odesa, S., Wu, T.C.J., Voscuhl, RR., Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann of Neurology 52:421-428, 2002.


2. Voskuhl, RR. “Gender Issues in Multiple Sclerosis” Current Neurology and Neuroscience Reports, 2:277-286, 2002.

1. Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf BR, Shi TS, Hokfelt T, Wasterlain C, Bartfai T, Langel U. Anticonvulsant activity of a nonpeptide galanin agonist. Proc. Natl Acad. Sci. (USA) 99: 7136-7141, 2002.


2. Tan Z, Sankar R, Tu W, Shin D, Liu H, Wasterlain CG, Schreiber SS. Differential induction of p53 in immature and adult rat brain following lithium-pilocarpine status epilepticus. Brain Res.928: 187-93, 2002.


3. Tan Z, Sankar R, Tu W, Shin D, Liu H, Wasterlain CG, Schreiber SS. Immunohistochemical study of p53-associated proteins in rat brain following lithium-pilocarpine status epilepticus. Brain Res.929: 129-38, 2002.


4. Mazarati AM, Wasterlain CG. Anticonvulsant activity of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus. Neurosci. Lett. 331:123-127, 2002.


5. Mazarati AM, Sofia D, Wasterlain CG. Anticonvulsant and antiepileptogenic effects of fluorofelbemete in experimental status epilepticus. Seizure, 11: 423-27, 2002.


6. Wasterlain, CG, Niquet J, Liu H, Sankar R, Mazarati AM, Suchomelova L, Katsumori H, Shirasaka Y. Seizure-induced neuronal death in the immature brain. Prog. Brain Res., 135:335-353, 2002.


7. Sankar R, Shin D, Wasterlain CG., Mazarati A., Epileptogenesis during development: injury, circuit recruitment, and plasticity. Epilepsia,43 (S 5): 47-53, 2002.


8. Wasterlain, C.G., A. M. Mazarati, H. Liu, Niquet J, Suchomelova L, Naylor D, U Langel, R. Sankar, Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus. Epilepsia, 43 (S 5): 20-29, 2002.


9. Mazarati AM, Bragin A, Baldwin R, Shin D, Wilson C, Sankar R, Naylor D, Engel JJr, Wasterlain CG, Epileptogenesis after self-sustaining status epilepticus. Epilepsia, 43 (S 5): 74-80, 2002.

1. Bragin, A, Wilson, CL, Engel, J Jr. Rate of interictal events an spontaneous seizures in epileptic rats after electrical stimulation of hippocampus and its afferents. Epilepsia., 43:S5 81-85 (2002).


2. Bragin, A., Mody, I., Wilson, C.L. and Engel, J. Jr. Local generation of fast ripples in epileptic brain. J. Neurosci. 22:2012-2021 (2002).


3. Bragin, A., Wilson C.L., Staba, R.J., Reddick, M., Fried, I., Engel, J. Jr. Interictal High Frequency Oscillations (80-500Hz) in the Human Epileptic Brain: Entorhinal Cortex. Annals of Neurology, 52: 407-415 (2002).


4. Bragin, A., Wilson, C.L. and Engel, J. Jr. Increased afterdischarge threshold during kindling in epileptic rats. Exp. Brain Res. 144:30-37, (2002).


5. Cornford, EM, Shamsa, K, Zeitzer, JM, Enriquez, CM, Wilson, CL, Behnke, EJ Fried, I, Engel, J Jr. Regional analyses of CNS microdialysate glucose and lactate in seizure patients. Epilepsia, 43: 360-371 (2002).


6. Engel, J. Jr., Wilson, C.L., Lopez-Rodriguez, F. Limbic connectivity: anatomical substrates of behavioral disturbances in epilepsy. In: Trimble, M., Schmitz, B. (Eds.), The Neuropsychiatry of Epilepsy. Cambridge: University Press, pp. 19-37 (2002).


7. Mazarati A, Bragin A, Baldwin R, Shin D, Wilson C, Sankar R, Naylor D, Engel J, Wasterlain CG. Epileptogenesis after self-sustaining status epilepticus. Epilepsia. 43 S5: 74-80 (2002).


8. Staba RJ, Wilson CL, Bragin A, Fried I, Engel J Jr. Quantitative analysis of high frequency oscillations (80-500Hz) recorded in human epileptic hippocampus and entorhinal cortex. J Neurophysiol. 88:1743-1752 (2002).


9. Staba RJ, Wilson CL, Bragin A, Fried I, Engel J Jr. Sleep states differentiate single neuron activity recorded from human epileptic hippocampus, entorhinal cortex and subiculum. J Neurosci.22: 5694-5704 (2002).


10. Staba RJ, Wilson CL, Fried I, Engel J Jr. Single neuron burst firing in the human hippocampus during sleep. Hippocampus. 12:724-734 (2002).


11. Zeitzer, JM, Maidment, NT, Behnke, EJ, Ackerson, L, Fried, I, Engel, J Jr and Wilson, CL Ultradian Sleep-Cycle variation of serotonin in the human lateral ventricle. Neurology:59:1272-1274 (2002).

1. Macey, P.M., Henderson, L.A., Macey, K.E., Alger, J.R., Frysinger, R.C., Woo, M.A., Harper, R.K., Yan-Go, F.L. & Harper, R.M. Brain morphology associated with obstructive sleep apnea. Am. J. Respir. Crit. Care Med., 166(10): 1382-7, 2002.


2. Yan-Go, F. & Garcia, R.E. “Insomnia and Other Sleep Conditions” In Janet P. Pregler and Alan H. DeCherney, (ed.), Principles of Women's Health, BC Decker, 639-651, 2002.


3. Craske M.G., Lang A.J., Mystkowski J.L., Zucker B.G., Bystritsky A. & Yan-Go F. Does nocturnal panic represent a more severe form of panic disorder? J Nerv Ment Dis, 190 (9): 611-8, 2002.

Craske
4. M.G., Lang A.J., Rowe M., DeCola J.P., Simmons J., Mann C., Yan-Go F. & Bystritsky A. Presleep attributions about arousal during sleep: nocturnal panic. J Abnorm Psychol. 2002 Feb;111(1):53-62.


5. Henderson LA, Macey PM, Macey KE, Frysinger RC, Woo MA, Harper RK, Alger JR, Yan-Go FL, Harper RM. Brain responses associated with the Valsalva maneuver revealed by functional magnetic resonance imaging. J Neurophysiol. 2002 Dec;88(6):3477-86.

Henderson,
6. L.A., Woo, M.A., Macey, P.M., Macey, K.E., Frysinger, R.C., Alger, J.R., Yan-Go, F. & Harper, R.M. Neural responses during Valsalva maneuvers in Obstructive Sleep Apnea Syndrome. J Appl Physiol. Published online Nov. 1, 2002 as 10.1152/japplohysiol.00702.2002.

BALOH, ROBERT

1. Ishiyama G, Ishiyama A, Baloh RW: Drop attacks and vertigo secondary to a non-Meniere otologic cause. Arch Neurol 2003;60:71-75.


2. Lee H, Whitman GT, Lim JG, Yi SD, Cho YU, Ying S, Baloh RW: Hearing symptoms in migrainous infarction. Arch Neurol 2003;60:113-116.


3. Baloh RW: Vestibular Neuritis. N Engl J Med 2003;348:1027-1032.


4. Lee, H Yi HA, Baloh RW: Sudden bilateral simultaneous deafness with vertigo as a sole manifestation of vertebrobasilar insufficiency. J Neurol Neurosurg Psychiatry 2003;74:539-541.


5. Sasaki O, Jen JC, Baloh RW, Kim GW, Isawa M, Usami S: Neurotological findings in a family with episodic ataxia. J Neurol 2003;250:373-375.


6. Lee H, Yi H, Cho YU, Sohn CH, Whitman GT, Ying S, Baloh, RW: Nodulus infarction mimicking acute peripheral vestibulopathy. Neurology 2003;60:1700-1702.


7. Ishiyama G, Lopez I, Baloh RW, Ishiyama A: Canavan's leukodystrophy is associated with defects in cochlear neurodevelopment and deafness. Neurology 2003;60:1702-1704.


8. Baloh RW, Ying SH, Jacobson KM: A longitudinal study of gait and balance dysfunction in normal older people. Arch. Neurol 2003;60:835-839.


9. Gopen Q, Lopez I, Ishiyama G, Baloh RW, Ishiyama A: Unbiased stereologic type I and type II hair cell counts in human utricular macula. Laryngoscope 2003;113:1132-1138.


10. Lopez I, Ishiyama G, Acuna D, Ishiyama A, Baloh RW: Immunolocalization of voltage-gated calcium channel alpha 1 subunits in the chinchilla cochlea. Cell Tissue Res 2003;313:177-186.


11. Maselli RA, Wan J, Dunne V, Graves M, Baloh RW, Wollman RL, Jen J: Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 2003;61:1743-1748.

1. Carmichael ST. Gene expression changes after focal stroke, traumatic brain and spinal cord injury. Curr Op Neurol 16:699-704, 2003.


2. Katsman D, Spinelli K, Zhang J, and Carmichael ST. Tissue microenvironments within functional cortical subdivisions adjacent to focal stroke. J Cereb Blood Flow Met 23:997-1009, 2003.


3. Carmichael ST. Cortical plasticity after stroke. Neuroscientist. 9:64-75, 2003.

1. Menalled L.B., Sison J.D., Dragatsis I., Zeitlin S., and Chesselet M-F: Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol. (2003) Oct 6:465(1):11-26.


2. Goldberg, MS., Fleming, S., Palacino, JJ., Cepeda, C., Lam, HA., Bhatnagar, A., Meloni, EG., Wu, N., Ackerson, LC., Klapstein, G., Gajendiran, M., Roth, BL., Chesselet, MF., Maidment, NT., Levine, MS., and Shen, J.: Parkin-deficient Mice Exhibit Nigrostriatal Deficits But Not Loss of Dopaminergic Neurons. J Biol Chem. (2003) October 31:279(44):43628-43635.


3. Chesselet M-F: Dopamine and Parkinson's disease: Is the Killer in the house? Molecular Psychiatry. 8 (2003) 369-370.


4. Hickey, M and Chesselet, M-F: Apoptosis in Huntington's Disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27 (2003) 255-265.


5. Hickey M.A. and Chesselet M.-F.: The use of transgenic and knock-in mice to study Huntington's disease, Cytogenetic and Genome Research. 100 (2003) 276-286.

1. Mendez MF, Cummings JL. Dementia: A Clinical Approach. Butterworths, Boston, (3rd edition, 2003). (Japanese translation 1986; Chinese translation 1987).


2. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB. Telomere shortening in T cells correlates with Alzheimer’s disease status. Neurobiol Aging 2003;24:77-84.


3. Cummings JL. 2-deoxy-2-[18F] fluoro-d-glucose positron emission tomography in Alzheimer’s diagnosis: time for technology transfer. (editorial). Mol Imag Bio 2003;4:385-386.


4. Sultzer DL, Brown CV, Mandelkern MA, Mahler ME, Mendez MF, Chen ST, Cummings JL. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer’s disease. Am J Psychiatry 2003;160:341-349.


5. Cummings JL. Alzheimer’s disease: from molecular biology to neuropsychiatry. Semin Clin Neuropsychiatry 2003;8:31-36.


6. Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2003;11:214-221.


7. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer disease. Arch Neurol 2003;60:393-398.


8. Cummings JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry 2003;11:131-145.


9. Clark DG, Cummings JL. Dementia diagnosis and management: an update. Intern Med J Thai 2003;19:61-68.


10. Porter VR, Buxton WG, Fairbanks LA, Strickland T, O’Connor SM, Rosenberg S, Cummings JL. Frequency and characteristics of anxiety among patients with Alzheimer’s disease and related dementias. J Neuropsychiatry Clin Neurosci 2003;15:180-186.


11. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, Sunderland T. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease. Am J Psychiatry 2003;160:857-866.


12. Senanarong V, Harnphadungkit K, Prayoonwiwat N, Poungvarin N, Sivasariyanonds N, Printarakul T, Udompunthurak S, Cummings JL. A new measurement of activities of daily living for Thai elderly with dementia. Int Psychogeriatric. 2003; 5:135-148.


13. Cummings JL, Jeste D. Pharmacotherapy of neuropsychiatric syndromes in neurologic disorders: definitional and regulatory aspects. The Econ Neurosci. 2003; 5; 36-40.


14. Swanberg MM, Cummings JL. Diagnosis and treatment of Alzheimer’s disease. The Econ Neurosci. 2003; 5; 55-62.


15. Cummings JL. The impact of depressive symptoms on patients with Alzheimer’s disease. Alzheimer’s Disease and Associated Disorders. 2003;17: 61-62.


16. Cummings JL. Toward a molecular neuropsychiatry of neurodegenerative diseases. Ann Neurol. 2003; 54:147-154.


17. Solomon DH, Wenger NS, Saliba D, Young RT, Adelman AM, Besdine RK, Blazer DG, Cassell CK, Cummings JL, Katz PR, Kitzman DW, Lavizzo-Mourey RJ, Mondoux LC, Popuvich R, Pories WJ, Wenger N. Appropriateness of quality indicators for older patients with advanced dementia and poor prognosis. J Am Geriatric Soc. 2003; 51:902-907.


18. Cole GM, Yang F, Lim GP, Cummings JL, Masterman DL, Frautschy SA. A rationale for curcuminoids for the prevention or treatment of Alzheimer’s disease. Curr. Med. Chem. – Imun., Endoc. & Metab. Agents. 2003; 3: 15-25.


19. Mendez M, Clark DG, Shapira JS, Cummings JL. Speech and language in progressive nonfluent aphasia compared with early Alzheimer’s disease. Neurology 2003; 61; 1108-1113.


20. Tractenberg RE, Singer CM, Cummings JL, Thal LJ. The sleep disorders inventory: an instrument for studies of sleep disturbance in persons with Alzheimer’s disease. J Sleep Res 2003; 12: 331-337.


21. Gustavson A, Cummings JL. Cholinesterase inhibitors in non-Alzheimer’s dementias. JAMDA.2003. November/December. S165-S169.


22. Sobrido MJ, Miller BL, Havlioglu N, Zhukareva V, Jiang Z, Nasreddine ZS, Le VMY, Chow TW, Wilhelmsen KC, Cummings JL, Wu JY, Geschwind DH. Novel tau polymorphisms, tau haplotypes and splicing in familial and sporadic frontotemporal dementia. Arch Neurol 2003; 60: 698-702.


23. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep 2003; 26: 893-901.


24. Cummings JL. Cognition and Behavior: the role of receptors and transmitters. In Cognitive and Behavioral Aspects of Neuropsychiatric Disorders. Potkin SG, Alva G, Cummings JL, Glazer WM, Juncos JL, Kanner AM, Pearl PL, Schatzberg AF, Spencer T (eds). 2002, pp. 2-50.


25. Swanberg MM, Cummings JL. Diagnosis and treatment of dementia. In: Neurological Disorders: Course and Treatment, 2nd edition. Elsevier Science, 2003, pp. 311-325.


26. Clark DG, Cummings JL. Aphasia. In: Neurological Disorders: Course and Treatment, 2nd edition. Elsevier Science, 2003, pp. 265-275.


27. Cummings JL. Trouble with speech and language. In: The Dana Guide to Brain Health. Bloom FE, Beal MF, Kupfer DJ. The Dana Press, New York, 2003, pp. 643-647.


28. Assal F, Cummings JL. Neurological signs in old age. In: Neurological Disorders: Course and Treatment, 2nd edition. Elsevier Science, 2003, pp. 541-548.


29. Tekin S, Cummings JL. Hallucinations and related conditions. In: Clinical Neuropsychology, 4th edition. Heilman KM, Valenstein E (eds). Oxford University Press, Oxford, 2003, pp. 479-494.


30. Cummings JL. Neuropsychiatric symptoms. In: Mild Cognitive Impairment, Aging to Alzheimer’s Disease. Petersen RC (ed). Oxford University Press, 2003, pp. 41-61.


31. Assal F, Cummings JL. Classification of dementias and cognitive disorders. In: Handbook of Medical Psychiatry. Soares JC, Gershon S (eds). Marcel Dekker, Inc., New York, 2003, pp. 99-115.


32. Swanberg MM, Nasreddine ZS, Mendez MF, Cummings JL. Speech and language. In: Textbook of Clinical Neurology. Goetz CG (ed). Saunders, 2003, pp. 77-97.


33. Tekin S, Cummings JL. Hallucinations, visual and auditory. In: Encyclopedia of the Neurological Sciences. Di-L Volume 2. Aminoff MJ, Daroff RB (eds). Academic Press, 2003, pp.500-503.


34. Guy SK, Cummings JL. The mental status exam. In: Behavioral Neurology and Neuropsychology, 2nd edition. Feinberg TE, Farah MJ (eds). McGraw-Hill, 2003, pp.23-32.


35. Kaufer DI, Cummings JL. Delirium and dementia: an overview. In: Behavioral Neurology and Neuropsychology, 2nd edition. Feinberg TE, Farah MJ (eds). McGraw-Hill, 2003, pp.495-514.


36. Hwang TJ, Cummings JL. Neuropsychiatric symptoms of mild cognitive impairment. In: Alzheimer’s Disease and Related Disorders Annual 2004. Gauthier S, Scheltens P, Cummings JL (eds). Martin Dunitz, 2003, pp.71-79.


37. Askin-Edgar S, White KE, Cummings JL. Neuropsychiatric aspects of Alzheimer’s disease and other dementing illnesses. In: Essentials of Neuropsychiatry and Clinical Neurosciences. Yudofsky SC, Hales RE (eds). American Psychiatric Publishing, 2003, pp.421-456.


38. Mendez M, Cummings JL. Neuropsychiatric aspects of aphasia. In: Essentials of Neuropsychiatry and Clinical Neuroscience. Yudofsky SC, Hales RE (ed). American Psychiatric Publishing, 2003, pp.189-200.


39. Hwang TJ, O’Conner S, Cummings JL. The use of the Neuropsychiatric Inventory in severe dementia. In: Research and Practice in Alzheimer’s Disease, Vol. 8. Vellass B, Fitten LJ, Winbald B, Feldman H, Grundman M, Giacobini E (eds). Serdi, 2003, pp. 100-106.


40. Assal F, Cummings JL. Cortical and frontosubcortical dementias; differential diagnosis. In: Dementia: Presentations, Differential Diagnosis, and Nosology, 2nd edition. Emery VOB and Oxman TE (eds). The Johns Hopkins University Press 2003, pp. 239-262.

1. DeGiorgio CM, Shewmon DA, Whitehurst T: Trigeminal nerve stimulation for epilepsy. Neurology 61(3):421-422, 2003.

1. Crane, B. T., Tian, J. R., Wiest, G., and Demer, J. L. Initiation of the human heave linear vestibulo-ocular reflex. Exp. Brain Res. 148: 247-255, 2003.


2. Demer, J. L. A 12 year, prospective study of extraocular muscle imaging in complex strabismus. J. AAPOS . 6: 337-47, 2003.


3. Goldberg R.A., Li T.G., Demer J.L. Diplopia following porous polyethylene orbital rim onlay implant. Ophthal Plast Reconstr Surg.19:83-85, 2003.


4. Miller, J. M., Demer, J. L., Poukens, V., Pavlowski, D. S., Nguyen, H. N., and Rossi, E. A. Extraocular connective tissue architecture. J. Vision 2: 12-23: 2003. (http://www.journalofvision.org/3/3/5/article.html)


5. Demer, J. L., Kono, R., Wright, W. Magnetic resonance imaging of human extraocular muscles in convergence. J. Neurophysiol. 9: 2072-2085, 2003. (http://oculus.jsei.ucla.edu/Papers.htm)


6. Demer, J. L. Oh, S. Y., Clark, R. A., and Poukens, V. Evidence for a pulley of the inferior oblique muscle. Invest. Ophthalmol. Vis. Sci. 44: 3856-3865, 2003.


7. Kono, R. and Demer, J. L. Magnetic resonance imaging of the functional anatomy of the inferior oblique muscle in superior oblique palsy. Ophthalmology 110:1219-1229, 2003.


8. Demer, J. L. Ocular kinematics, vergence, and orbital mechanics. Strabismus. 11: 49-57, 2003.


9. Tian, J –R., Crane, B. T., and Demer, J. L. Vestibular catch-up saccades augmenting the human transient heave linear vestibulo-ocular reflex. Exp. Brain Res., 151:435-445, 2003.


10. Detorakis, E. T., Engstrom, R. E., Straatsma, B. R., and Demer, J. L. Functional anatomy of the anophthalmic socket: Insights from magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci., 44: 4307-13, 2003.


11. Yamada, K., Andrews, C., Chan, W-M., McKeown, C. A., Magli, A., de Berardinis, T., Loewenstein, A., Lazar, M., O’Keefe, M., Letson, R., London, A., Ruttum, M., Matsumoto, N., Saito, N., Morris, L., Del Monte, M., Johnson, R. H., Uyama, E., Houtman, W. A., de Vries, B., Carlow, T,. J., Hart, B. L., Krawiecki, N., Schoffner, J., Vogel, M. C., Katowitz, J., Goldstein, S. M., Levin, A. L., Sener, E. C., Ozturk, B. T., Akarsu, A. N., Brodsky, M. C., Hanisch, R., Cruse, R. P., Zubcov, A. A., Robb, R. M., Roggenkaemper, P., Gottlob, I., Kowal, L., Battu, R., Traboulsi, E. I., Franceschini, P., Newlin, A., Demer, J. L., and Engle, E. C. Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Nat. Genetics. 35: 318-21, 2003.

1. Dobkin BH, Apple D, Barbeau H, et al. for the Spinal Cord Injury Locomotor Trial Group. Methods for a randomized trial of weight-supported treadmill training versus conventional training for walking during inpatient rehabilitation after incomplete traumatic spinal cord injury. Neurorehabil Neural Repair 17:153-167, 2003.


2. Dobkin BH. Do electrically stimulated sensory inputs and movements lead to long-term plasticity and rehabilitation gains? Curr Opin Neurol 16: 685-691, 2003.


3. Dobkin BH. The Clinical Science of Neurologic Rehabilitation: Oxford University Press, New York, 2003.


4. Dobkin, BH. “The Neuroscientific bases for task-oriented rehabilitation,” In, Advances in Clinical Neurosciences, Sinha, KK, Chandra P, eds., Catholic Press, India, 2003.

1. Avanzini, G., de Boer, H.M., De Castro, S., Engel, J. Jr., Lee, P. and Sabaté, E. Epilepsy. In: Adherence to Long-Term Therapies: Evidence for action. Geneva: World Health Organization, 2003, pp 87-93.


2. Bragin, A., Wilson, C.L. and Engel, J. Jr. Spatial stability over time of brain areas generating fast ripples in the epileptic rat. Epilepsia 44:1233-1237, 2003.


3. Engel, J. Jr. A greater role for surgical treatment of epilepsy: Why and when? Epilepsy Currents 3:37-40, 2003.


4. Engel, J. Jr. Bringing epilepsy out of the shadows. Neurology 60:1412, 2003.


5. Engel, J. Jr. Epilepsy, overview. In: Aminoff, M. and Daroff, R. (Eds.), Encyclopedia of the Neurological Sciences. San Diego: Academic Press, 2003, pp 218-223.


6. Engel, J. Jr. More aggressive epilepsy surgery? Practical Neurology 2:25-27, 2003. Engel, J. Jr. Reply to “Of cabbages and kings. Some considerations on classification, diagnostic schemes, semiology, and concepts.” Epilepsia 44:4-6, 2003.


7. Engel, J. Jr., Wiebe, S., French, J., Gumnit, R., Spencer, D., Sperling, M., Williamson, P., Zahn, C., Westbrook, E. and Enos, B. Practice parameter: Temporal lobe and localized neocortical resections for epilepsy. Neurology 60:538-547, 2003.


8. Engel, J. Jr., Wilson, C. and Bragin, A. Advances in understanding the process of epileptogenesis based on patient material: What can the patient tell us? Epilepsia 44(Suppl. 12):60-71, 2003.


9. Lopez-Rodriguez, F., Wilson, C.L., Maidment, N.T., Poland, R.E. and Engel, J. Jr. Total sleep deprivation increases extracellular serotonin in the rat hippocampus. Neuroscience 121:523-530, 2003.


10. Lopez-Rodriguez, F., Wilson, C.L., Maidment, N.T., Poland, R.E., Chase, M.H. and Engel, J. Jr. Extracellular serotonin in the rat hippocampus during REM sleep deprivation. Sleep Research Online 5:115-122, 2003.


11. Stern, J.M. and Engel, J. Jr. Epilepsy, precipitating factors. In: Aminoff, M. and Daroff, R. (Eds.), Encyclopedia of the Neurological Sciences. San Diego: Academic Press, 2003, pp 223-224.


12. Stern, J.M. and Engel, J. Jr. Epilepsy, surgery. In: Aminoff, M. and Daroff, R. (Eds.), Encyclopedia of the Neurological Sciences. San Diego: Academic Press, 2003, pp 247-250.
    


13. Swarztrauber, K., Dewar, S. and Engel, J. Jr. Patient attitudes about treatments for intractable epilepsy. Epilepsy and Behavior 4:19-25, 2003.


14. Engel, J. Jr. (Assoc. Ed.), Epilepsy Section in Encyclopedia of the Neurological Sciences, edited by M. Aminoff and R.B. Daroff. San Diego, Academic Press, 2003.

1. Cole, Gm, Yang, F., Lim, GP, Cumming, JL, Masterman, DL, frautschy, SA. A rationale for curcuminoids for the prevention or treatment of alzheimer's disease. Curr Med Chem. Immun. Endocr. & Metab. Agents 2003: 3: 15-25.

1. Niquet, J, Baldwin, RA, Allen, SG, Fujikawa, DG and Wasterlain, CG. Hypoxic neuronal necrosis: protein synthesis-independent activation of a cell death program. Proc Natl Acad Sci (USA), 100: 2825-2830, 2003.


2. Fujikawa, DG. Neuronal death in mesial temporal sclerosis: separating morphology from mechanism. Epilepsia, 44: 1607, 2003 (comment).

1. Sobrido M-J, Abu-Khalil A, Weintraub S, Johnson N, Quinn B, Cummings JL, Mesulam M-M, Geschwind DH. Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neurology 60: 862-864, 2003.


2. Sobrido M-J, Miller BL, Havlioglu N, Zhukareva V, Jiang Z, Nasreddine ZS, Lee VM-Y, Chow TW, Wilhelmsen KC, Cummings JL, Wu JY, Geschwind DH. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Archives of Neurology 60:698-702, 2003.


3. Fu L, Abu-Khalil A, Morrison RS, Geschwind DH, Kornblum HI. Expression patterns of epidermal growth factor receptor and fibroblast growth factor receptor 1 mRNA in fetal human brain. Journal of Comparative Neurology 462:265-273, 2003.


4. Karsten SL, Kudo LC, Jackson R, Sabatti C, Kornblum HI, Geschwind DH. Global analysis of gene expression in neural progenitors reveals specific cell-cycle, signaling, and metabolic networks. Developmental Biology 261:165-182, 2003.


5. Compton P, Geschwind DH, Alarcón M. Association between human µ-opioid receptor gene polymorphism, pain tolerance and opioid addiction. American Journal of Medical Genetics 121:76-82, 2003.


6. Yonan AL, Alarcón M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, Grunn A, Juo S-H, Terwilliger JD, Liu J, Cantor RM, Geschwind DH*, Gilliam TC. (*corresponding author). A genomewide screen of 345 families for autism-susceptibility loci. American Journal of Human Genetics 73:886-897, 2003.


7. Fales CL, Knowlton BJ, Holyoak KJ, Geschwind DH, Swerdloff RS, Gonzalo IG. Working memory and relational reasoning in Klinefelter syndrome. J Int Neuropsychol Soc 9:839-846, 2003.


8. Simpson JL, de la Cruz F, Swerdloff RS, Samango-Sprouse C, Skakkebaek NE, Graham JM Jr, Hassold T, Aylstock M, Meyer-Bahlburg RF, Willard HF, Hall JG, Salameh W, Boone K, Staessen C, Geschwind D, Giedd J, Dobs AS, Rogol A, Brinton B, Paulsen CA. Klinefelter’s syndrome: Expanding the phenotype and identifying new research directions. Genetics in Medicine 5:460-468, 2003.


9. Cáceres M, Lachuer J, Zapala MA, Redmond JC, Kudo L, Geschwind DH, Lockhart DJ, Preuss TM, Barlow C. Elevated gene expression levels distinguish human from non-human primate brains. Proceedings of the National Academy of Sciences USA 100:13030-13035, 2003.


10. Easterday MC, Dougherty JD, Jackson RL, Ou J, Nakano I, Paucar AA, Roobini B, Dianati M, Irvin DK, Weissman IL, Terskikh AV, Geschwind DH, Kornblum HI. Neural progenitor genes: Germinal zone expression and analysis of genetic overlap in stem cell populations. Developmental Biology 264:309-322, 2003.


11. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI. Cancerous stem cells can arise from pediatric brain tumors. Proceedings of the National Academy of Sciences USA 100:15178-15183, 2003.


12. Geschwind DH. DNA microarrays: Translation of the genome from laboratory to clinic. The Lancet Neurology 2:275-282, 2003.


13. Geschwind DH (2003). Tau phosphorylation, tangles, and neurodegeneration: The chicken or the egg? Neuron 40:457-460.

1. Beres-Jones, J.A., T.D. Johnson, S.J. Harkema. Clonus after human spinal cord injury cannot be attributed solely to recurrent muscle-tendon stretch. Exp Brain Res, 149, 222-236, 2003.


2. Dobkin, B.H., D. Apple, H. Barbeau, M. Basso, A. Behrman, D. Deforge, J. Ditunno, G. Dudley, R. Elashoff, L. Fugate, S. Harkema, M. Saulino, M. Scott. Methods for a randomized trial of weight-supported treadmill training versus conventional training for walking during inpatient rehabilitation after incomplete traumatic spinal cord injury. Neurorehabilitation & Neural Repair, 17, 3, 153-167, 2003.


3. Johnson, T.D., R.M. Elashoff, and S.J. Harkema. A Bayesian change-point analysis of electromyographic data: detecting muscle activation patterns and associated applications. Biostatistics, 4, 1, 143-164, 2003.

1. Keesey J: The role of Herman Hoppe of Cincinnati in the initial clinical recognition of myasthenia gravis. J History Neurosciences 12:167-174, 2003.


2. Kaminski (ed.): Myasthenia Gravis and Related Diseases, Muscle & Nerve May 2003.

1. Koski, L., Iacoboni, M., Dubeau, M-C., Woods, R.P. & Mazziotta, J.C. Modulation of cortical activity during different imitative behaviors. J. Neurophysiol. 89:460-471, 2003.


2. Heiser, M., Iacoboni, M., Maeda, F., Marcus, J. & Mazziotta, J. The essential role of Broca’s area in imitation. Fed Europ Neuroscience Societies. 17: 1123-1128, 2003.


3. Carr, L., Iacoboni, M., Dubeau, M-C., Mazziotta, J. & Lenzi, G-L. Neural mechanisms of empathy in humans: A relay from neural systems for action representation to limbic areas. PNAS. 100(9): 5497-5502, 2003.


4. Quintana, J., Wong, T., Ortiz-Portillo, E., Marder, S. & Mazziotta, J. Right lateral fusiform gyrus dysfunction during facial information processing in schizophrenia. Biological Psychiatry. 53(12): 1099-1112, 2003.


5. Sicotte, N.L., Voskuhl, R.R., Bouvier, S., Klutch, R., Cohen, M.S. & Mazziotta, J.C. Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla. Invest Radiol. 38(7): 423-427, 2003.


6. Kochunov, P., Fox, P., Lancaster, J., Tan, L.H., Amunts, K., Zilles, K., Mazziota, J. & Gao, J.H. Localized morphological brain differences between English-speaking and Chinese-speaking Asians: New evidence of anatomical plasticity. NeuroReport. 14(7): 961-964, 2003.


7. Luders E, Rex DE, Narr KL, Woods RP, Jancke L, Thompson PM, Mazziotta JC, Toga AW. Relationships between sulcal asymmetries and corpus callosum size: Gender and handedness effects. Cerebral Cortex. 13(10): 1084-1093, 2003.

1. Johnson, KP, Brooks, BR, Ford, CC, Goodman, AD, Lisak, RP, Myers, LW, Pruitt, AA, Rizzo, MA, Rose, JW, Weiner, LP, and Wolinsky, JS. Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-tear organized multiple sclerosis trial. Multiple Sclerosis 9: 585-591, 2003.

1. Perlman, SL. Diagnostic Evaluation of Ataxic Patients. In: SM Pulst (ed) Genetics of Movement Disorders. Academic Press, San Diego, 2003.


2. Perlman, SL. Spinocerebellar Degeneration. Expert Opinions in Pharmacotherapy 4:1637-1641, 2003.

1. Panossian LA, Porter VR, Valenzuela HF, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging. 2003 Jan-Feb;24(1):77-84.


2. Porter VR, Buxton WG, Fairbanks LA, Strickland T, O'Connor SM, Rosenberg-Thompson S, Cummings JL. Frequency and characteristics of anxiety among patients with Alzheimer's disease and related dementias. J Neuropsychiatry Clin Neurosci. 2003 Spring; 15(2): 180-6.

1. Rausch, R, Kraemer, S, Pietras, C, Le, M, Vickrey, B, and Passaro, E. Early and late cognitive changes following temporal lobe surgery for epilepsy. Neurology, 2003 Mar 25 60:6 951-959.

1. Ovbiagele B, Kidwell CS, Saver JL. Epidemiological impactin the United States of a tissue-based definition of transient ischemic attack. Stroke 2003;34:919-924.


2. Vespa PM, O’Phelan K, Shah M, Mirabelli J, Starkman S, Kidwell C, Saver J, Nuwer MR, Frazee JG, McArthur DA, Martin NA. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003;60:1441-1446.


3. Kidwell CS, Shephard T, Tonn S, Lawyer B, Murdock M, Koroshetz W, Alberts M, Hademenos GJ, Saver JL. Establishment of primary stroke centers: a survey of physician attitudes and hospital resources. Neurology 2003;60:1452-1456.


4. Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis 2003;16:280-285.


5. Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Villablanca JP, Vespa PM, Kidwell CS. Perfuson-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003;34:1425-1430.


6. Fisher M, for the Stroke Therapy Academic Industry Roundtable. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke 2003;34:1539-1546.


7. Leary MC, Kidwell CS, Villablanca JP, Starkman S, Jahan R, Duckwiler GR, Gobin YP, Sykes S, Gough KJ, Ferguson K, Llanes JN, Masamed R, Tremwel M, Ovbiagele B, Vespa PM, Vinuela F, Saver JL. Validation of computed tomographic middle cerebral artery "dot" sign: An angiographic correlation study. Stroke 2003;34:2636-2640.


8. Saver JL, Kidwell CS. MRI in transient ischemic attacks: clinical utility and insights into pathophysiology. In: Davis S, Fisher M, Warach S, eds. Magnetic Resonance Imaging in Stroke. Cambridge, Cambridge University Press, 2003, 135-146.


9. Saver JL. A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA (letter). Neurology 2003;60:1871.

1. DeGiorgio CM, Shewmon DA, Whitehurst T: Trigeminal nerve stimulation for epilepsy. Neurology 61(3):421-422, 2003.

1. Levitt JG, Blanton RE, Smalley S, Thompson PM, Guthrie D, McCracken JT, Sadoun T, Heinichen L & Toga AW. Cortical sulcal maps in autism, Cerebral Cortex, 13(7):728.35, 2003.


2. Kochunuv P, Lancaster J, Thompson P, Toga AW, Brewer P, Hardies J & Fox P. An optimized individual target brain in the talairach coordinate system, NeuroImage, 17(2):922-927, 2003.


3. Toga AW & Thompson PM. Mapping brain asymmetry, Nature Reviews Neuroscience, 4:37-48, 2003.


4. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL & Toga AW. Mapping cortical change across the human life span, Nature Neuroscience, 6(3):309-315, 2003.


5. Sheth S, Nemoto M, Walker M, Guiou M, Pouratian N & Toga AW. Evaluation of coupling between optical intrinsic signals and neuronal activity in rat somatosensory cortex, NeuroImage, 19:884-894, 2003.


6. Thompson P, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, Herman D, Hong MS, Dittmer SS, Doddrell DM & Toga AW. Dynamics of gray matter loss in Alzheimer’s disease, Jrnl. of Neuroscience, 23(3): 994-1005, 2003.


7. Thompson PM & Toga AW. Cerebral cortex diseases & cortical localization, Nature Encyclopedia of the Life Sciences, London: Nature Publishing Group. http://www.els.net/ [doi:10.1038/npg.els.00021956]. April 2003.


8. Toga AW & Thompson P. Temporal dynamics of brain anatomy, Ann. Rev. of Biomed. Engineering, 5:119-45, 2003.


9. Rex DE, Ma JQ & Toga AW. The LONI pipeline processing environment, NeuroImage, 19:1033-1048, 2003.


10. Gardner D, Toga AW, Ascoli GA, Beatty J, Brinkley JF, Dale AM, Fox PT, Garnder EP, George JS, Goddard N, Harris KM, Herskovits EH, Hines M, Jacobs GA, Jacobs RE, Jones EG, Kennedy DN, Kimberg DY, Mazziotta JC, Miller P, Mori S, Mountain DC, Reiss AL, Rosen GD, Rottenberg DA, Shepherd GM, Smallheiser NR, Smith KP, Strachan T, Van Essen DC, Williams RW, Wong STC. Towards effective and rewarding data sharing, Neuroinformatics, 1(3):289-296, 2003.


11. Pouratian N, Bookheimer SY, Rubino G, Martin NA & Toga AW. Category-specific naming deficit identified by preoperative fMRI, stimulation mapping and neuropsychological testing: Case report, J. Neurosurg., 99:170-176, 2003.


12. Lueders E, Rex DE, Narr KL, Woods RP, Jancke L, Thompson PM, Mazziotta JC & Toga AW. Relationships between sulcal asymmetries and corpus callosum size: gender and handedness effects, Cerebral Cortex, 13:1084-1093, 2003.


13. Narr KL, Sharma T, Woods RP, Thompson PM, Sowell ER, Rex D, Kim S, Asuncion D, Jang S, Mazziotta J & Toga AW. Increases in regional subarachnoid CSF without apparent cortical gray matter deficits in schizophrenia: Modulating effects of sex and age, Am. J. Psychiatry, 160:2169-2180), 2003.


14. Pouratian N, Sheth S, Bookheimer SY, Martin NA & Toga AW. The applications and limitations of perfusion-dependent functional brain mapping for neurosurgical guidance, Neurosurgical Focus,15(1):1-8, 2003.


15. Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, Pham D & Kumar A. Anterior cingulate, gyrus rectus and orbitofrontal abnormalities in elderly depressed patients: an MRI based parcellation of the prefrontal cortex, Am. J. Psychiatry, 161(1):99-108, 2003.


16. Pouratian N, Sheth SA, Martin NA & Toga AW. Shedding light on brain mapping: Advances in human optical imaging, TRENDS in Neurosci., 26(5):277-282, 2003.


17. Cannestra AF, Wartenburger I, Villringer A & Toga AW. Functional assessment of Broca’s area using near infrared spectroscopy in humans, NeuroReport, 14(15):1961-1965, 2003.


18. MacKenzie-Graham A, Jones ES, Shattuck DW, Dinov ID, Bota M & Toga AW. The informatics of a C57BL/6J Mouse Brain Atlas, Neuroinformatics, 1:397-410, 2003.


19. Lancaster JL, Kochunov PV, Thompson PM, Toga AW & Fox PT. Asymmetry of the brain surface from deformation field analysis, Human Brain Mapping, 19:79-89, 2003.


20. Sowell ER, Thompson PM, Welcome SE, Henkenius AL, Toga AW & Peterson BS. Cortical abnormalities in children and adolescents with attention deficit hyperactivity disorder, The Lancet, 362 (9397):1699-1707, 2003.


21. Levitt J, O’Neill J, McCracken JT, Toga AW & Alger JA. Proton magnetic resonance spectroscopic imaging of brain metabolic abnormalities in childhood autism, Biological Psychiatry, 54(12): 1355-1366, 2003.


22. Cannon TD, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Cornblatt B, Keshavan M, Malaspina D, Seidman L, Tsuang M, Maier W. Early and late neurodevelopmental influences in the prodrome to Schizophrenia: Contributions of genes, environment and their interactions, Schizophrenia Bulletin, 29(4):653-69, 2003.


23. Xu M, Thompson P & Toga AW. An adaptive level set segmentation of a triangulated mesh, IEEE Trans. on Med. Imag., 23(2):191-201, 2003.


24. Ballmaier M, Sowell ER, Thompson PM, Kumar A, Lavretsky H, Welcome SE, DeLuca H & Toga AW. Mapping brain size and cortical gray matter changes in elderly depression, Biological Psychiatry, 55:382-389, 2003.


25. Narr K, Green MF, Capetillo-Cunliffe L, Toga AW & Zaidel E. Lateralized lexical decision in Schizophrenia: Hemispheric specialization and interhemispheric lexicality priming, J. Abnormal Psy., 112(4):623-32, 2003.


26. Sheth SA, Nemoto M, Guiou M, Walker M, Pouratian N, Hageman N & Toga AW. Columnar specificity of microvascular oxygenation and volume responses: Implications for functional brain mapping, J Neuroscience, 24(3):634-641, 2003.


27. Ballmaier M, Toga AW, Siddarth P, Blanton RE, Levitt JG, Lee M & Caplan R. Thought disorder and nucleus accumbens in childhood: A structural MRI study, Psyc. Res.: Neuroimaging, 130(1):43-55, 2003.

1. Berg AT, Langfitt J, Shinnar S, Vickrey BG, Sperling MR, Walczak T, Bazil C, Pacia SV, Spencer S. How long does it take for partial epilepsy to become intractable? Neurology 2003;60:186-190.


2. Berg AT, Vickrey BG, Langfitt J, Sperling MR, Walczak T, Shinnar S, Bazil C, Pacia SV, Spencer SS. The Multicenter Epilepsy Surgery Study: Recruitment and selection for surgery. Epilepsia 2003;44:1425-1433.


3. Kim S, Hays RD, Birbeck G, Vickrey BG. Responsiveness of the Quality of Life in Epilepsy Inventory (QOLIE-89) in an antiepileptic drug trial. Quality of Life Research 2003;12:147-155.


4. Rausch R, Kraemer S, Pietras C, Le M, Vickrey B, Passaro E. Early and late cognitive changes following temporal lobe surgery for epilepsy. Neurology 2003;60:951-959.


5. Ringel SP, Vickrey BG, Schembri M, Kravitz RL. Neurologists’ assessment of their ability to provide high quality care. Neurology 2003;61:612-615.


6. Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Shinnar S, Langfitt JT, Walczak TS, Pacia S, Ebrahimi N, Frobish D. Initial outcomes in the multicenter study of epilepsy surgery. Neurology 2003;61:1680-1685.

Birbeck G, Vickrey BG. Determinants of health-related quality
7. of life in adults with psychogenic nonepileptic seizures: Are there implications for clinical practice? Epilepsia 2003;44:141-142.


8. Vickrey BG, Holloway RG. Evidence-based medicine. In: NeurologicalTherapeutics: Principles and Practice. Noseworthy J, ed. London. Martin Dunitz Ltd. 2003:49-54.

Berg AT, Langfitt J, Shinnar S, Vickrey BG, Sperling MR,
9. Walczak T, Bazil C, Pacia SV, Spencer SS. Reply from the authors regarding “How long does it take for partial epilepsy to become intractable?” Neurology 2003; 61:277.


10. Vickrey BG. Neurologists and acute stroke care. Journal Watch Neurology 2003;5:89-90.

1. Niquet, J, Baldwin, RA, Allen, SG, Fujikawa, DG, Wasterlain, CG. Hypoxic neuronal necrosis: protein synthesis-independent activation of a cell death program. Proc. Natl Acad. Sci. (USA), 100(5): 2825-2830, 2003.

1. Bragin A, Wilson CL, Engel J Jr. Spatial stability over time of brain areas generating fast ripples in the epileptic rat. Epilepsia. 44: 1233-1237 (2003).


2. Engel J Jr, Wilson C, Bragin A. Advances in understanding the process of epileptogenesis based on patient material: what can the patient tell us? Epilepsia.; 44 Suppl 12: 60-71 (2003).


3. Fuller M, Wilson CL, Velasco AL, Dunn JR, Zoeger J. On the confirmation of an effect of magnetic fields on the interictal firing rate of epileptic patients. Brain Research Bulletin 60: 43–52 (2003).


4. Lopez-Rodriguez F, Wilson CL, Maidment NT, Poland RE, Engel J. Total sleep deprivation


5. increases extracellular serotonin in the rat hippocampus. Neuroscience, 121:523-530 (2003).

1. Harper RM, Macey PM, Henderson LA, Woo MA, Macey KE, Frysinger RC, Alger JR, Nguyen KP, Yan-Go FL. fMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects. J Appl Physiol. 2003 Apr;94(4):1583-95. Epub 2003 Jan 03.


2. Macey PM, Macey KE, Henderson LA, Alger JR, Frysinger RC, Woo MA, Yan-Go F, Harper RM. Functional magnetic resonance imaging responses to expiratory loading in obstructive sleep apnea. Respir Physiol Neurobiol. 2003 Nov 14;138(2-3):275-90.